Publication | Open Access
Rational design of chimeric antigen receptor T cells against glypican 3 decouples toxicity from therapeutic efficacy
23
Citations
35
References
2022
Year
By combining the reduced-affinity CAR with this exogenous control mechanism, we provide evidence that we can modulate and control CAR-mediated toxicity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1